sharetrader
Page 3 of 25 FirstFirst 123456713 ... LastLast
Results 31 to 45 of 373
  1. #31
    Advanced Member
    Join Date
    May 2015
    Posts
    2,319

    Default

    https://www.nzx.com/files/attachments/230971.pdf

    A great start for a newly listed company!

  2. #32
    A BEARISH BULL winner69's Avatar
    Join Date
    Jun 2001
    Location
    , , .
    Posts
    26,507

    Default

    Quote Originally Posted by trader_jackson View Post
    https://www.nzx.com/files/attachments/230971.pdf

    A great start for a newly listed company!
    Interesting

    Share price back to $3 plus on this news?
    “Just consider that maybe the probability of you being wrong is higher than you think.”

  3. #33
    Advanced Member
    Join Date
    May 2015
    Posts
    2,319

    Default

    Quote Originally Posted by winner69 View Post
    Interesting

    Share price back to $3 plus on this news?
    https://www.nzx.com/companies/AFT/announcements/279472

    Probably back over $3 now! "significant boost in sales"

    AFT has only been listed for just under 3 months, and they have already announced a couple of very positive announcements.

    Disclosure: Happy Holder

  4. #34
    Guru
    Join Date
    Feb 2010
    Posts
    3,833

    Default

    Doesnt look like a chance, by the depth---You sure like those speculative plays TJ!

  5. #35
    Advanced Member
    Join Date
    May 2015
    Posts
    2,319

    Default

    https://www.nzx.com/companies/AFT/announcements/279815

    Simply stunning, one would think this sort of break through would certainly push it over $3!

  6. #36
    Guru
    Join Date
    Feb 2010
    Posts
    3,833

    Default

    I dunno tJ--Im still looking at the depth--sell 4551@285---buy 400@275

    Im not surprised they got approval--its a combination of 2 of the most common ingredients around--just doesnt seem like the sort of thing to take the medical world by storm--(no reason not to use it though--Im sure it will keep selling,but I think you will need some sort of breakthrough (from the research)to really make traction.
    Right now there is heaps of positivity on the NZX so if it doesnt happen today ,or soon,might be alot of waiting.

  7. #37
    Member
    Join Date
    Feb 2016
    Posts
    38

    Default

    Quote Originally Posted by trader_jackson View Post
    https://www.nzx.com/companies/AFT/announcements/279815

    Simply stunning, one would think this sort of break through would certainly push it over $3!
    Cautiously optimistic. An initial step in what will be a long process for FDA approval in clinical application.

    Here's the link to one of their trials from the US if your clinically inclined. https://clinicaltrials.gov/ct2/show/NCT02689063
    It is similar to the trial which will be piloted in Christchurch

    Speaking to my colleagues in the pain management field, there are still a myriad of issues concerning IV administration of NSAIDs
    Last edited by BC_Doc; 24-03-2016 at 12:13 PM.

  8. #38
    Advanced Member
    Join Date
    May 2015
    Posts
    2,319

    Default

    https://www.nzx.com/companies/AFT/announcements/282071

    https://www.nzx.com/companies/AFT/announcements/282070

    Solid announcements, leading up to what will hopefully be an impressive full year results announcement on Wednesday May 25 2016 (around 9am)

  9. #39
    Guru
    Join Date
    Feb 2010
    Posts
    3,833

    Default

    The big question is just how much dosh they are churning through with the research,and whether they are coming up with anything--I wonder if they would not be better off just promoting their established product(but whats the difference between just taking 1/2 tab of ibuprofen and 1/2 of paracetimal (i did the spell check on the misspelling of para and it told me ''malpractice'' --you gotta laugh sometimes)

    Theres probably a big difference but Ive often wondered

  10. #40
    percy
    Join Date
    Oct 2009
    Location
    christchurch
    Posts
    14,136

    Default

    I was asked by my chemist what I thought of AFT.
    Told him I would find out what I could.
    So 96,834,838 shares on issue,giving at $2.95 a market capitalisation of $285,662,772.
    Half year to 30th September 2015;
    Revenue $29,543,000
    Nett loss $6,367,000.
    Next report due 25th May .
    Conculsion.The market is factoring in a lot of "blue skies".Be careful.

  11. #41
    Advanced Member
    Join Date
    May 2015
    Posts
    2,319

    Default

    https://www.nzx.com/files/attachments/236150.pdf

    On the face of it, what was interesting for me:
    - "losses" (when excluding Research and development expenses and Equity accounted loss of joint venture entity) increased slightly from $204k to $564k
    - gross profit up almost 12%, with margins reasonably strong (not showing singes of dramatic decreases in gross margin to try sell more!)
    - Australia is doing very well (and probably continue to grow in double digits)
    - Rest of world will probably continue to treble in sales for the next few years
    - NZ is performing "solidly" but will probably continue at mid single digits due to saturation (great to see market share is growing!)

    Look forward to hearing what others are thinking, but this looks to be a keeper!

    Disclosure: of course I'm holding!

  12. #42
    Advanced Member
    Join Date
    May 2015
    Posts
    2,319

    Default

    http://www.sharechat.co.nz/article/a...two-years.html

    Anyone go?

    Presentation didn't look to exciting, but it's good to see things are tracking well

  13. #43
    Junior Member
    Join Date
    Sep 2016
    Posts
    18

    Default

    Quote Originally Posted by skid View Post
    The big question is just how much dosh they are churning through with the research,and whether they are coming up with anything--I wonder if they would not be better off just promoting their established product(but whats the difference between just taking 1/2 tab of ibuprofen and 1/2 of paracetimal (i did the spell check on the misspelling of para and it told me ''malpractice'' --you gotta laugh sometimes)

    Theres probably a big difference but Ive often wondered
    Taking paracetamol and ibuprofen together is effectively the same, and a lot of doctors do actually prescribe this for post-operative pain relief (particularly with the current push to get away from opiate-based analgesics). However, in theory it's best for patient safety and compliance to simplify a prescription as much as possible (one tablet is better than two). As far as over-the-counter use is concerned, I imagine that users who find that a combination is best for their particular pain would also prefer to have a packet of the all-in-one tablet, plus it's safer if the combination dose is pre-measured instead of having a situation where consumers have to mix and match.

    What I'm most interested in is whether they have a US sales partner lined up and what sort of marketing effort will be directed toward US healthcare providers.

  14. #44
    A BEARISH BULL winner69's Avatar
    Join Date
    Jun 2001
    Location
    , , .
    Posts
    26,507

    Default

    One day the share price might surge up

    Impressive sales chart in annoucement

    https://www.nzx.com/files/attachments/243361.pdf
    “Just consider that maybe the probability of you being wrong is higher than you think.”

  15. #45
    Guru
    Join Date
    Feb 2010
    Posts
    3,833

    Default

    Quote Originally Posted by jimbo View Post
    Taking paracetamol and ibuprofen together is effectively the same, and a lot of doctors do actually prescribe this for post-operative pain relief (particularly with the current push to get away from opiate-based analgesics). However, in theory it's best for patient safety and compliance to simplify a prescription as much as possible (one tablet is better than two). As far as over-the-counter use is concerned, I imagine that users who find that a combination is best for their particular pain would also prefer to have a packet of the all-in-one tablet, plus it's safer if the combination dose is pre-measured instead of having a situation where consumers have to mix and match.

    What I'm most interested in is whether they have a US sales partner lined up and what sort of marketing effort will be directed toward US healthcare providers.
    Thats the million dollar question--IMO thats where PEB has stumbled...no big US partner

Bookmarks

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •